Condition: Multiple Myeloma · Sponsor: Canadian Cancer Trials Group
Currently, daratumumab or isatuximab are given continuously (non-stop), along side lenalidomide, and dexamethasone as part of multiple myeloma treatment. are given continuously (non-stop). Recent observations suggest that stopping daratumumab or isatuximb after about a year and a half of treatment may work just as well as giving them continuously with lenalidomide and dexamethasone. Sometimes, bortezomib is also given. This study is being done to answer the question: is less daratumumab or isatuximab treatment as good as more?
This description comes directly from the study's public registry record.
Annette Hay · 613-533-6430 · ahay@ctg.queensu.ca
Always discuss trial participation with your own doctor first.
| Cross Cancer Institute | Edmonton, Alberta, Canada | Recruiting |
| BCCA - Kelowna | Kelowna, British Columbia, Canada | Recruiting |
| BCCA - Vancouver | Vancouver, British Columbia, Canada | Recruiting |
| CancerCare Manitoba | Winnipeg, Manitoba, Canada | Recruiting |
| The Moncton Hospital | Moncton, New Brunswick, Canada | Recruiting |
| Regional Health Authority B, Zone 2 | Saint John, New Brunswick, Canada | Recruiting |
| Dr. H. Bliss Murphy Cancer Centre | St. John's, Newfoundland and Labrador, Canada | Recruiting |
| Royal Victoria Regional Health Centre | Barrie, Ontario, Canada | Recruiting |
| William Osler Health System | Brampton, Ontario, Canada | Recruiting |
| Juravinski Cancer Centre at Hamilton Health Sciences | Hamilton, Ontario, Canada | Recruiting |
| Kingston Health Sciences Centre | Kingston, Ontario, Canada | Recruiting |
| Waterloo Regional Health Network (WRHN) | Kitchener, Ontario, Canada | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06182774